1-(800)-800-3332

Study Finds Unaggressive Prostate Tumors in Men Unlikely To Result in Death

Posted on September 3, 2015 by Disability Help Group

Many believe that hearing a diagnosis of prostate cancer is a death sentence. However, new research recently published in the Journal of Clinical Oncology explains that relatively unaggressive prostate cancer is unlikely to cause death in most men.

Research from the Brady Urological Institute at John Hopkins University followed the long-term prognosis of 1,298 men who were diagnosed with prostate tumors that were low or very low risk of aggressiveness. Of these men, only two died of cancer over a 15-year follow-up period and only three developed metastatic disease.

The men in the study were actively monitored by a urologist who performed annual biopsies on the prostate tumors. This active surveillance allows doctors to identify when a cancer was becoming aggressive and apply more prompt treatment.

The researchers note, “Our study should reassure men that carefully selected patients enrolled in active surveillance programs for their low-risk prostate cancers are not likely to be harmed by their disease.”

Prostate Cancer Is One of the Leading Disabling Cancers in Men

Aggressive types of prostate cancer can require intensive treatment that leaves most men fatigued and too ill to continue their regular employment. If you have been diagnosed with aggressive prostate cancer and can no longer work and earn a substantial income, you may qualify for Social Security disability benefits. Men who served in the Vietnam War may also qualify for veterans disability benefits from the Department of Veterans Affairs (VA) due to presumptive exposure to Agent Orange.

The Disability Help Group assists people with disabilities file their disability claims or appeal a decision. We help with Social Security disability claims for Social Security Disability Insurance (SSDI), Supplemental Security Income (SSI), and veterans disability claims with the VA. Contact us online or call us at 1-(800)-800-3332.